Dr. Soliman Abdel Kader Fakeeh Hospital Company (TADAWUL:4017)
33.20
+0.12 (0.36%)
Oct 15, 2026, 3:10 PM AST
TADAWUL:4017 Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, TADAWUL:4017 stock has a consensus rating of "Hold" and an average price target of SAR 39.10. The average 1-year stock price forecast is 17.77% higher than the current stock price, while the lowest is SAR 36.00 (+8.43%) and the highest is SAR 41.50 (+25.00%).
Price Target: SAR 39.10 (+17.77%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for TADAWUL:4017 stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 5 | 5 | 4 | 4 |
Financial Forecast
Revenue This Year
3.85B
from 3.09B
Increased by 24.51%
Revenue Next Year
4.44B
from 3.85B
Increased by 15.51%
EPS This Year
1.51
from 1.26
Increased by 19.84%
EPS Next Year
1.38
from 1.51
Decreased by -8.52%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.